文献速递颈动脉与弓上血管

女性在颈动脉血运重建前后接受卒中预防最佳药物治疗的比例低于男性

Females are less likely to receive best medical therapy for stroke prevention before and after carotid revascularization than males.
PubMed 文献 · J Vasc Surg · 2022-10-12

该回顾性研究基于血管质量倡议数据库2003年1月至2022年2月接受颈动脉内膜切除术或颈动脉支架置入术的214008例患者,女性占38.7%。女性术前接受最佳药物治疗的比例为77.2%,低于男性的80.4%(P < .001),校正后女性术前接受最佳药物治疗的比值比男性低11%(校正比值比0.89,95%置信区间0.86-0.91),术后低18%(校正比值比0.82,95%置信区间0.79-0.84)。接受最佳药物治疗的患者院内卒中、死亡及卒中/死亡均显著更低(均P < .001)。

要点

  • 女性术前最佳药物治疗比例77.2%,低于男性80.4%(P < .001)。
  • 校正后女性术前接受最佳药物治疗的比值比男性低11%(校正比值比0.89,95%置信区间0.86-0.91)。
  • 接受最佳药物治疗者院内卒中、死亡及卒中/死亡均显著更低(均P < .001)。

核心结论

  • 女性在颈动脉血运重建前接受卒中预防最佳药物治疗的比例显著低于男性。
  • 未接受最佳药物治疗的患者院内结局更差,提示需提高术前对卒中预防指南的依从性。

研究设计与样本

  • 回顾性分析血管质量倡议数据库中2003年1月至2022年2月接受颈动脉内膜切除术或颈动脉支架置入术的患者。
  • 共纳入214008例患者,女性82855例(38.7%),男性131153例(61.3%)。
  • 采用多变量逻辑回归模型校正社会人口学、合并症和疾病严重程度特征后评估性别与术前最佳药物治疗的关联。
  • 按性别和术前最佳药物治疗状态评估院内结局。

主要发现

  • 女性术前接受最佳药物治疗的比例为77.2%(63922例),男性为80.4%(105375例),P < .001。
  • 校正基线差异后,女性术前接受最佳药物治疗的比值比男性低11%(校正比值比0.89,95%置信区间0.86-0.91)。
  • 术后女性接受最佳药物治疗处方的比值比男性低18%(校正比值比0.82,95%置信区间0.79-0.84)。
  • 接受最佳药物治疗的患者院内卒中发生率1.20% vs 未接受者1.51%,死亡0.37% vs 0.66%,卒中/死亡1.46% vs 1.98%,均显著更低(均P < .001)。

临床怎么用

  • 原文结论指出需提高对卒中预防指南的术前依从性,尤其关注女性患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current professional guidelines recommend best medical therapy (BMT) with statin agents and antiplatelet therapy for primary and secondary stroke prevention in patients with carotid artery stenosis. We aimed to assess the association of patient sex with preoperative BMT in patients undergoing carotid revascularization. METHODS: We performed a retrospective review of Vascular Quality Initiative patients who underwent carotid endarterectomy or carotid artery stenting between January 2003 and February 2022. Multivariable logistic regression models were used to assess the association of patient sex with preoperative BMT after adjusting for sociodemographic, comorbidity, and disease severity characteristics. In-hospital outcomes were assessed by sex and preoperative BMT status. RESULTS: Of 214,008 patients who underwent carotid revascularization, 38.7% (n = 82,855) were female and 61.3% (n = 131,153) were male. Overall, 77.2% (n = 63,922) of females were on preoperative BMT, compared with 80.4% (n = 105,375) of males (P < .001). After adjusting for baseline differences, females had 11% lower odds of being on BMT compared with males (adjusted odds ratio, 0.89; 95% confidence interval, 0.86-0.91). Postoperatively, females had 18% lower odds of being prescribed BMT than males (adjusted odds ratio, 0.82; 95% confidence interval, 0.79-0.84). In-hospital stroke (1.20% vs 1.51%), death (0.37% vs 0.66%), and stroke/death (1.46% vs 1.98%) were all significantly lower for patients on BMT (all P < .001). CONCLUSIONS: There is a significant discrepancy in the proportion of females versus males receiving preoperative BMT for stroke prevention before carotid artery revascularization. In-hospital outcomes are worse in patients without BMT, highlighting the importance of raising awareness and implementing targeted interventions to improve preoperative adherence to stroke prevention guidelines.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bose S, Stonko DP, Pappas GM, et al. Females are less likely to receive best medical therapy for stroke prevention before and after carotid revascularization than males. J Vasc Surg. 2022. PMID: 36241125. doi:10.1016/j.jvs.2022.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。